文献速递术前评估与围术期医学疼痛医学

非阿片类镇痛药与辅助药用于肥胖手术患者多模式镇痛:系统综述与网状Meta分析

Efficacy of nonopioid analgesics and adjuvants in multimodal analgesia for reducing postoperative opioid consumption and complications in obesity: a systematic review and network meta-analysis.
PubMed 文献 · Br J Anaesth · 2024-10-03

该系统综述与网状Meta分析纳入37项RCT共3602例成人肥胖手术患者,评估非阿片类静脉镇痛药与辅助药减少围术期阿片消耗及并发症的效果。右美托咪定、氯胺酮、利多卡因、镁剂和加巴喷丁显著减少术后阿片消耗,氯胺酮/艾司氯胺酮显著减少术后肺部并发症,右美托咪定和利多卡因等对恶心呕吐及住院时长有改善作用。

要点

  • 右美托咪定、氯胺酮、利多卡因、镁剂和加巴喷丁可显著减少肥胖手术患者术后阿片消耗。
  • 氯胺酮/艾司氯胺酮显著减少术后肺部并发症(POPCs)。
  • 右美托咪定减少PACU停留时间,对乙酰氨基酚和利多卡因减少住院时长。

核心结论

  • 静脉非阿片类镇痛药与辅助药在多模式麻醉中对成人肥胖手术患者至关重要,可减少阿片消耗并改善术后管理。

研究设计与样本

  • 系统综述与网状Meta分析,检索PubMed、Scopus、Web of Science、CINAHL和EMBASE,仅纳入英文RCT。
  • 纳入37项RCT共3602例成人肥胖手术患者。
  • 使用RoB 2工具评估偏倚风险,GRADE框架评估证据质量与确定性。
  • 系统综述方案注册号CRD42023399373(PROSPERO)。

主要发现

  • 与安慰剂/无干预或对照相比,右美托咪定、氯胺酮、利多卡因、镁剂和加巴喷丁显著减少术后阿片消耗。
  • 氯胺酮/艾司氯胺酮显著减少术后肺部并发症(POPCs)。
  • 布洛芬、右美托咪定和利多卡因显著减少术后恶心,右美托咪定(单用或联合普瑞巴林)和利多卡因减少术后呕吐。
  • 右美托咪定显著减少PACU停留时间,对乙酰氨基酚和利多卡因减少住院时长。

临床怎么用

  • 肥胖手术患者多模式镇痛中可考虑静脉使用右美托咪定、氯胺酮、利多卡因、镁剂或加巴喷丁以减少阿片消耗。
  • 氯胺酮/艾司氯胺酮可用于减少术后肺部并发症风险。
  • 右美托咪定可用于缩短PACU停留时间,对乙酰氨基酚或利多卡因可用于缩短住院时长。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Managing postoperative pain in patients with obesity is challenging. Although multimodal analgesia has proved effective for pain relief, the specific impacts of different nonopioid i.v. analgesics and adjuvants on these patients are not well-defined. This study aims to assess the effectiveness of nonsteroidal antiinflammatory drugs, paracetamol, ketamine, α-2 adrenergic receptor agonists, lidocaine, magnesium, and oral gabapentinoids in reducing perioperative opioid consumption and, secondarily, in mitigating the occurrence of general and postoperative pulmonary complications (POPCs), nausea, vomiting, PACU length of stay (LOS), and hospital LOS among surgical patients with obesity. METHODS: A systematic review and network meta-analysis was performed. PubMed, Scopus, Web of Science, CINAHL, and EMBASE were searched. Only English-language RCTs investigating the use of nonopioid analgesics and adjuvants in adult surgical patients with obesity were included. The quality of evidence and certainty were assessed using the RoB 2 tool and GRADE framework, respectively. RESULTS: In total, 37 RCTs involving 3602 patients were included in the quantitative analysis. Compared with placebo/no intervention or a comparator, dexmedetomidine, ketamine, lidocaine, magnesium, and gabapentin significantly reduced postoperative opioid consumption after surgery. Ketamine/esketamine also significantly reduced POPCs. Ibuprofen, dexmedetomidine, and lidocaine significantly reduced postoperative nausea, whereas dexmedetomidine, either alone or combined with pregabalin, and lidocaine reduced postoperative vomiting. Dexmedetomidine significantly reduced PACU LOS, whereas both paracetamol and lidocaine reduced hospital LOS. CONCLUSIONS: Intravenous nonopioid analgesics and adjuvants are crucial in multimodal anaesthesia, reducing opioid consumption and enhancing postoperative care in adult surgical patients with obesity. SYSTEMATIC REVIEW PROTOCOL: CRD42023399373 (PROSPERO).

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Carron M, Tamburini E, Linassi F, et al. Efficacy of nonopioid analgesics and adjuvants in multimodal analgesia for reducing postoperative opioid consumption and complications in obesity: a systematic review and network meta-analysis. Br J Anaesth. 2024. PMID: 39366846. doi:10.1016/j.bja.2024.08.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。